1-20 of 99
Bing Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adult acute myeloid leukemia with NUP98 rearrangement benefits from targeted therapy and bone marrow transplantation

Free
Hongming Zhu, Yunxiang Zhang, Xia Li, Huafeng Wang, Huarong Zhou, Fengbo Jin, Zhenqi Huang, Yu Zhu, Zheng Ge, Ying Lu, Weimin Chen, Bing Xu, Taigang Zhu, Xiaofei Yang, Shaolei Zang, Chunyan Ji, Qingshu Zeng, Shaoyuan Wang, Suning Chen, Jie Jin, Jiong Hu, Yang Shen, Junmin Li, East China Leukemia Alliance (Ecla)
Journal: Blood
Blood (2025) 146 (Supplement 1): 3391.
https://doi.org/10.1182/blood-2025-3391
Published: 2025
Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Free
Yuhong Ren, Jia Liu, Zhijuan Lin, Lihong Shou, Hui Zeng, Dong Wu, Zhiyong Zeng, Fengping Zhou, Li Bao, Hongmei Jing, Songfu Jiang, Haisheng Liu, Jianzhen Shen, Wenjuan Yu, Hui Zhou, Jingyan Xu, Yan Zhang, Ting Wang, Honghui Huang, Bing Xu, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7229.
https://doi.org/10.1182/blood-2025-7229
Published: 2025
Journal Articles

Real-world, multicenter study of brentuximab vedotin-based regimens in Chinese patients with relapsed/refractory Hodgkin lymphoma

Free
Yuxuan Che, Ruolan Zeng, Dabei Tang, Ou Bai, Youchao Jia, Yuhuan Gao, Xiaojing Yan, Xiaolei Ding, Xiuli Sun, Xiaobo Wang, Bing Xu, Hui-Han Wang, Dongxia Qu, Liye Xu, Na Li, Qingyuan Zhang, Hui Zhou, Xiuhua Sun
Journal: Blood
Blood (2025) 146 (Supplement 1): 7142.
https://doi.org/10.1182/blood-2025-7142
Published: 2025
Journal Articles

Orelabrutinib plus rituximab-based chemoimmunotherapy regimens in relapsed or refractory marginal zone lymphoma: A multicentric phase II trial

Free
Shaohua Wu, Li Ma, Jingrong Wang, Xiaolian Wen, Meijing Zheng, Bing Xu, Hongling Ma, Yanli Wang, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 7117.
https://doi.org/10.1182/blood-2025-7117
Published: 2025
Journal Articles

Preliminary study results of orelabrutinib in combination with rituximab for treatment-Naïve marginal zone lymphoma: A prospective single-arm clinical trial

Free
Zhifeng Li, Hua Wang, Zhijuan Lin, Li Yu, Shaojie Wu, Na Qin, Jie Zha, Long Liu, Manman Deng, Bing Xu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3580.
https://doi.org/10.1182/blood-2025-3580
Published: 2025
Journal Articles

A first-in-human, phase I/II, open-label, multicenter, dose escalation and expansion study of lbl-034, a conditionally activated bispecific antibody targeting GPRC5D and CD3 with a 2:1 format, in patients with relapsed/refractory multiple myeloma

Free
Xuelin Dou, Yuping Zhong, Wanhong Zhao, Ling Qin, Xin Du, Aijun Liao, Zhongjun Xia, Chunyan Sun, Songfu Jiang, Dongping Huang, Haitang Xie, Liangming Ma, Jishi Wang, Fengyan Jin, Guifang Ouyang, Yanhong Tong, Min Dong, Bing Xu, Wenduo He, Shengli Cai, Jin Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 91.
https://doi.org/10.1182/blood-2025-91
Published: 2025
Journal Articles

Zanubrutinib plus obinutuzumab induces promising efficacy and a manageable safety profile in previously untreated high-tumor-burden follicular lymphoma

Free
Zhijuan Lin, Long Liu, Manman Deng, Xingxing Yu, Yan Hong, Hua Wang, Keshu Zhou, Shaojie Wu, Ting-Bo Liu, Na Qin, Rui Su, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2025) 146 (Supplement 1): 1818.
https://doi.org/10.1182/blood-2025-1818
Published: 2025
Journal Articles

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma in Chinese population: A single-arm, multicenter, phase 2 trial

Free
Zhengming Jin, Huilai Zhang, Changju Qu, Wenbin Qian, Keshu Zhou, Wenrong Huang, Bing Xu, Hongmei Jing, Wenyu Li, Kang Yu, Ting Niu, Wei LIU, Xi Zhang, Yuhua Li, Huiqiang Huang, Haiyan Yang, Hua Yang, Wei Xu, Jinghua Zhao, Depei Wu
Journal: Blood
Blood (2025) 146 (Supplement 1): 1796.
https://doi.org/10.1182/blood-2025-1796
Published: 2025
Journal Articles

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with azacitidine and  Chidamide can be an effective chemotherapy regimen for patients with angioimmunoblastic T-cell lymphoma (AITL)

Free
Yanli Wang, Xuliang Shen, Guoxiang Zhang, Li Liang, Li Ma, Bing Xu, Jingrong Wang, Shaohua Wu, Min Bai, Xiaolian Wen, Le Li, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 3652.
https://doi.org/10.1182/blood-2025-3652
Published: 2025
Journal Articles

A chemo-free tumor microenvironment (TME) reshaping regimen combining glofitamab induces a high CR rate in relapsed/refractory diffuse large B cell lymphoma (DLBCL)

Free
Zhijuan Lin, Long Liu, Xingxing Yu, Yan Hong, Manman Deng, Daogui Li, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3738.
https://doi.org/10.1182/blood-2025-3738
Published: 2025
Journal Articles

Thyroid diffuse large B-cell lymphoma in China: Multicenter study of diagnosis, clinical features, treatment efficacy, prognostic factors, and genomic alterations

Free
Fei Li, Hao Sun, Guohui Cui, Ou Bai, Shenmiao Yang, zunmin zhu, Peiqi Zhao, Keqian Shi, keshu zhou, Siguo Hao, Jia Wei, Hui Zhou, Kaiyang Ding, Xiangxiang Zhou, Honghui Huang, Ting-Bo Liu, fan zhou, Bing Xu, Aibin Liang, Shuye Wang, Ru Feng, Wenyu Shi, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 1902.
https://doi.org/10.1182/blood-2025-1902
Published: 2025
Journal Articles

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with rituximab, gemcitabine, dexamethasone, and cisplatin (R-GDPM) in Relapsed/Refractory diffuse large B-cell lymphoma: A multicenter, single-arm study

Free
Li Ma, Jin Zhao, Jingrong Wang, Bing Xu, Meijing Zheng, Junyuan Lang, Xiaolian Wen, Bin Yang, Shaohua Wu, Yanli Wang, Li Liang, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 5476.
https://doi.org/10.1182/blood-2025-5476
Published: 2025
Journal Articles

Rituximab, cyclophosphamide, mitoxantrone hydrochloride liposome, vincristine, and prednisone (R-CMOP) in elderly patients with newly diagnosed diffuse large B-cell lymphoma: A multicenter, prospective study

Free
Xiaolian Wen, Lieyang Wang, Li Ma, Bing Xu, Yanping Ma, Jingrong Wang, Shaohua Wu, Jin Zhao, Zhiqiang Zhao, Yalan Wang, Jie Liu, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 3697.
https://doi.org/10.1182/blood-2025-3697
Published: 2025
Journal Articles

Characteristics and clinical outcomes of ND-AML patients with bcor/bcorl1 mutations

Free
Shaolei Zang, Chunyan Ji, Xiaosheng Fang, Qingshu Zeng, Suning Chen, Zheng Ge, Zhiling Yan, Junmin Li, Yu Zhu, Shaoyuan Wang, Min Ji, Zhenqi Huang, Xueqing Dou, Hongming Zhu, Bing Xu, Huarong Zhou, Zhiyong Zeng, Hao Chen, Jingtao Wang, Huafeng Wang, Jie Jin, Jingjing Ye, East China Leukemia Alliance China
Journal: Blood
Blood (2025) 146 (Supplement 1): 7005.
https://doi.org/10.1182/blood-2025-7005
Published: 2025
Journal Articles

A predictive model based on NCCN-IPI and 2 pirnas for prognostic risk stratification of diffuse large B-cell lymphoma (DLBCL)

Free
Min Zhang, Tao Guan, Bing Xu, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 3667.
https://doi.org/10.1182/blood-2025-3667
Published: 2025
Journal Articles

Neuronal-Glial and Immune Microenvironment Signatures Show Prognostic Effects in Primary CNS Lymphoma

Free
Zijun Y. Xu-Monette, Xiaoxiao Wang, Govind Bhagat, Alexandar Tzankov, Qingyan Au, Carlo Visco, Harry Nunns, Alessandro La Ferlita, Lalit Sehgal, April Chiu, Heounjeong Go, Anamarija M. Perry, Huilan Rao, Mina Xu, Qiongli Zhai, Yafei Wang, Shi Wang, Wenbin Qian, Maurilio Ponzoni, Wen Shuai, Bangchen Wang, Sergio Pina-Oviedo, Luis Carrillo, Kelly Au, Santiago Montes-Moreno, Sr., Karen Dybkaer, Zenggang Pan, William Choi, Michael Møller, Luigi Racioppi, Xiaohui Zhang, Jinming Song, Shanxiang Zhang, Youli Zu, Joo Y. Song, Eric D. Hsi, Fenghuang Zhan, Benjamin M. Parsons, Aliyah R. Sohani, Weina Chen, Fabio Iwamoto, Jeremy S. Abramson, Bing Xu, Yong Li, Ken H. Young
Journal: Blood
Blood (2024) 144 (Supplement 1): 4361.
https://doi.org/10.1182/blood-2024-201598
Published: 2024
Journal Articles

Suvmax Linked to Intrafollicular Macrophage Infiltration Is Associated with Poor Outcome of Follicular Lymphoma

Free
Zhijuan Lin, Xingxing Yu, Yan Hong, Long Liu, Jie Zha, Bing Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4379.
https://doi.org/10.1182/blood-2024-205432
Published: 2024
Journal Articles

A China Survey on the Insights of Patients Living with Follicular Lymphoma: The Real-World Patient Journey Analysis

Free
Yang He, Huilai Zhang, Bing Xu, Zengjun Li, Zheng Song, Qiuhui Jiang, Hui Wang, Weili Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 7622.
https://doi.org/10.1182/blood-2024-206977
Published: 2024
Journal Articles

Spatial Architecture of Immune Microenvironment Orchestrating Anti-Lymphoma Immunity and the Response to Immunochemotherapy in EBV+ Diffused Large B Cell Lymphoma Revealed By Imaging Mass Cytometry and Spatial Transcriptome

Free
Zhijuan Lin, Xingxing Yu, Yan Hong, Long Liu, Zhifeng Li, Jie Zha, Bing Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 452.
https://doi.org/10.1182/blood-2024-210210
Published: 2024
Journal Articles

CD163+ Macrophages Orchestrate Tumor Immunity By Spatially Fortifying Follicular Lymphoma Against CD8+ T Cells Attack during Early Progression

Free
Zhijuan Lin, Xingxing Yu, Yan Hong, Long Liu, Zhifeng Li, Jie Zha, Bing Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1621.
https://doi.org/10.1182/blood-2024-207677
Published: 2024